ALTERITY THERAPEUTICS-ADR (ATHE) Stock Balance Sheet
NASDAQ:ATHE - Nasdaq - US02155X2053 - ADR - Currency: USD
| MRQ (2024-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 9.00M | |||
| Cash Equivalents | 4.54M | N/A | 34.81M | 28.12M | 192.70K | |||
| Receivables | 5.68M | N/A | 4.73M | 4.28M | 61.30K | |||
| Other Current Assets | 210.50K | N/A | 1.61M | 1.10M | 578.10K | |||
| Total Current Assets | 10.43M | N/A | 41.14M | 33.49M | 9.84M | |||
| Non-Current Assets | ||||||||
| PPE Net | 115.80K | N/A | 218.50K | 96.80K | 71.40K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 115.70K | N/A | 218.50K | 96.80K | 71.30K | |||
| TOTAL ASSETS | 10.55M | N/A | 41.36M | 33.59M | 9.91M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | N/A | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 62.70K | N/A | 57.60K | 27.80K | 32.90K | |||
| Accrued Expenses | N/A | N/A | 2.33M | 1.02M | 1.10M | |||
| Accounts Payable | 2.05M | N/A | 2.69M | 1.45M | 954.00K | |||
| Other Current Liabilities | 604.20K | N/A | 740.80K | 571.20K | 623.00K | |||
| Total Current Liabilities | 2.72M | N/A | 5.82M | 3.07M | 2.71M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 43.10K | N/A | 59.90K | 37.90K | 900.00 | |||
| Other Non-Current Liabilities | N/A | N/A | 13.80K | 9.80K | 41.50K | |||
| Total Non-Current Liabilities | 43.10K | N/A | 73.60K | 47.70K | 42.40K | |||
| TOTAL LIABILITIES | 2.76M | N/A | 5.89M | 3.12M | 2.76M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -215.73M | N/A | -178.32M | -166.98M | -153.55M | |||
| Additional Paid In Capital | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 223.52M | N/A | 213.79M | 197.45M | 160.70M | |||
| Shares Outstanding | 15.37M | N/A | 6.95M | 6.02M | 3.00M | |||
| Tangible Book Value per Share | 0.00 | N/A | 0.01 | 0.01 | 0.01 | |||
| Total Shareholders' Equity | 7.79M | N/A | 35.47M | 30.47M | 7.15M | |||
| TOTAL LIABILITIES AND EQUITY | 10.55M | N/A | 41.36M | 33.59M | 9.91M | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | N/A | 0.00 | 0.00 | 0.00 | |||
| Current Ratio | 3.84 | N/A | 7.07 | 10.92 | 3.62 | |||
| Return On Assets (ROA) | -187.63% | N/A | -31.06% | -45.58% | -135.82% | |||
| Return On Equity (ROE) | -254.17% | N/A | -36.22% | -50.24% | -188.19% | |||
All data in AUD , ROIC based on taxRate of 0.21